Latest Legal Fees News

Kaiser Reef reports a solid cash boost to $30.7 million driven by strong production from its Henty and A1 gold mines, while clarifying its gold price risk management strategy.

Noumi Limited reported a nearly flat Q4 FY25 revenue with mixed segment performances and flagged a net loss for the year amid legacy legal expenses. The company highlights growth in its Milklab brand and export sales while managing significant convertible note obligations.

SIV Capital Limited reported a positive net cash flow for Q4 FY25 and holds $8.177 million in cash, while evaluating a new acquisition opportunity despite ongoing ASX suspension.

DGR Global Limited reports steady progress in project generation and subsidiary investments, bolstered by a $23.5 million loan facility and a favorable legal appeal outcome. The company maintains a strong health, safety, and environmental record while navigating challenging market conditions.

Tombador Iron Limited reported a solid cash position of AUD 9.549 million as it advances the acquisition of the Colomi Iron Project in Brazil, while navigating royalty income challenges and preparing for a capital raise.

Fintech Chain Limited has applied to delist from the ASX, citing low valuation, poor liquidity, and high costs, aiming to unlock growth capital in China and the US.

AF Legal Group has resolved a significant legal claim related to a senior lawyer's 2022 hire, incurring up to $600,000 in costs, while navigating an ongoing regulatory probe. Despite these challenges, the firm remains optimistic about improved profitability in the second half of FY25.

DGR Global Limited reported steady progress in project generation and strategic investments during Q1 2025, while navigating ongoing legal challenges and securing a $23.5 million funding facility to support operations and refinancing.

Health and Plant Protein Group Limited has dramatically reduced its half-year net loss to $43,000 following the divestment of its macadamia division, though uncertainty lingers over a significant IRS receivable in the US.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.

Cardiex Limited reported a $2.94 million cash outflow for Q2 FY2025 but bolstered its balance sheet with a $3.25 million placement. The company has begun delivering its CONNEQT Pulse units, signaling a new revenue stream and ongoing R&D investment.

Nagambie Resources has updated its JORC Inferred Resource at the Nagambie Mine, reflecting higher gold and antimony prices and ongoing drilling efforts to expand and upgrade the deposit.